Alison Holmes is a Professor of Infectious Diseases and Director of Infection Prevention and Control (DIPC) for Imperial College Healthcare NHS Trust.
Professor Holmes is the Director of the NIHR Health Protection Research Unit (HPRU) in Healthcare Associated Infection and Antimicrobial Resistance. Together with Public Health England Lead Alan Johnson, Professor Holmes directs the work of 4 themes: Applied molecular bacteriology, Applied data linkage, syndromic surveillance and modelling, Innovations in behaviour change, technology and patient safety to improve infection prevention and antimicrobial use and Organisational change, health economics, sustainability and evaluation. The HPRU, which was established on 1 April 2014, is a partnership between Imperial College London, Public Health England, Cambridge University Veterinary School, the Wellcome Trust Sanger Institute and Imperial College Health Partners North West London Academic Health Science Network.
Alison is also Co-Director of the UKCRC funded National Centre for Infection Prevention and Management.
Alison graduated from Cambridge and London. Following work in communicable diseases in Oxford, she won a Glaxo training fellowship in Infectious Diseases which she completed in Boston and also obtained a Masters in Public Health at Harvard. She established and developed the syllabus for the MSc in Infection Management for Pharmacists in the UK, which she now co-runs. She is author of numerous papers and book chapters and is on the editorial boards of the Journal of Hospital Infection and the International Journal of Health and Human Rights.
Alison has served on a secondment to the Department of Health as a National Clinical Champion and advisor on reducing hospital acquired infection, and is a member of various national strategy committees. She serves on several other national committees on antibiotic prescribing, education and surveillance. She is an expert member on the Governmental Advisory Committee on Antimicrobial Resistance and Healthcare Associated Infection (ARHAI) and is a programme leader at the Centre for Patient Safety & Service Quality.
et al., 2016, Understanding the mechanisms and drivers of antimicrobial resistance, Lancet, Vol:387, ISSN:0140-6736, Pages:176-187
et al., 2016, Increased airway glucose increases airway bacterial load in hyperglycaemia, Scientific Reports, Vol:6, ISSN:2045-2322
et al., 2016, Isolation demand from carbapenemase-producing Enterobacteriaceae screening strategies based on a West London hospital network., J Hosp Infect
et al., 2016, International cooperation to improve access to and sustain effectiveness of antimicrobials, Lancet, Vol:387, ISSN:0140-6736, Pages:296-307
et al., 2016, Innovative tools for quality assessment: integrated quality criteria for review of multiple study designs (ICROMS), Public Health, Vol:133, ISSN:0033-3506, Pages:19-37